Abstract
In many ways, this trial illustrates the dangers in the interpretation of early clinical trials data. The many pitfalls for the unwary reader are incorporated into the study design and the subsequent publication. On this basis, alone, it has become a “classic.”
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
9.1 Key Trial References
9.1.1 Major Publication
Padma-Nathan H, Hellstrom W, et al. Treatment of men with erectile dysfunction with transurethral alprostadil. N Engl J Med 336:1–7, 1997.
9.1.2 Original Abstract
Padma-Nathan H. Treatment of men with erectile dysfunction with transurethral alprostadil. American Urological Association 1996.
9.1.3 Other Important Publications
Engel J, McVary K. Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy. Urology 51(5):687–692, 1998.
Fulgham P, Cochran J, et al. Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practise setting. J Urol 160(6 Pt 1):2041–2046, 1998.
Rights and permissions
Copyright information
© 2007 Springer-Verlag London Limited
About this chapter
Cite this chapter
(2007). Now-Classic Study on the Use of Intraurethral Prostaglandin E1 (Alprostadil). In: Key Clinical Trials in Erectile Dysfunction. Springer, London. https://doi.org/10.1007/978-1-84628-428-1_9
Download citation
DOI: https://doi.org/10.1007/978-1-84628-428-1_9
Publisher Name: Springer, London
Print ISBN: 978-1-84628-427-4
Online ISBN: 978-1-84628-428-1
eBook Packages: MedicineMedicine (R0)